Adherence to adjuvant endocrine therapy for breast cancer: Importance in women with low income

Carling J. Ursem, Hayden B. Bosworth, Rebecca A. Shelby, Wenke Hwang, Roger T. Anderson, Gretchen G. Kimmick

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

There are wide disparities in breast cancer-specific survival by patient sociodemographic characteristics. Women of lower income, for instance, have higher relapse and death rates from breast cancer. One possible contributing factor for this disparity is low use of adjuvant endocrine therapy - an extremely efficacious therapy in women with early stage, hormone receptor positive breast cancer, the most common subtype of breast cancer. Alone, adjuvant endocrine therapy decreases breast cancer recurrence by 50% and death by 30%. Data suggest that low use of adjuvant endocrine therapy is a potentially important and modifiable risk factor for poor outcome in low-income breast cancer patients.

Original languageEnglish (US)
Pages (from-to)403-408
Number of pages6
JournalJournal of Women's Health
Volume24
Issue number5
DOIs
StatePublished - May 1 2015

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Adherence to adjuvant endocrine therapy for breast cancer: Importance in women with low income'. Together they form a unique fingerprint.

Cite this